Rising Demand for Preventive Healthcare Fuels Nutraceutical Excipients Growth
According to a recent research report, the global nutraceutical excipients market is projected to grow from USD 4.2 billion in 2023 to USD 6.1 billion by 2028, at a CAGR of 7.7%. This growth is fueled by the rising demand for nutraceuticals that support preventive healthcare and address a wide range of health conditions.
Rising Role of Nutraceuticals in Healthcare
Nutraceuticals have gained immense popularity in recent years due to their ability to support diverse therapeutic needs. From cancer and cardiovascular care to insomnia, memory loss, and stress-induced headaches, nutraceuticals are being embraced for both preventive and supportive treatment.
Traditional blends like ginger, garlic, and honey continue to gain consumer trust, while modern formulations featuring green tea, Vitamin C, and Vitamin E are increasingly sought after for improving hair health, skin issues, fatigue, and even mental wellness. This trend is opening new opportunities for the pharma and food industries, particularly as consumers take a proactive approach to managing health.
Request Custom Data to Address your Specific Business Needs
Key Growth Drivers
Several factors are accelerating the growth of the nutraceutical excipients market:
* Aging population and higher prevalence of chronic diseases
* Rising healthcare costs, driving consumers toward preventive solutions
* Advances in food technology and nutrition enabling better formulations
* Greater awareness of the diet-health connection among consumers
As demand for nutraceuticals increases, the need for specialized excipients that enhance product efficacy, stability, and delivery systems grows in parallel.
Organic Chemicals Lead the Way
Among product sources, organic chemicals dominate due to consumer preference for natural ingredients, reduced allergenic risks, and alignment with the clean label trend.
With growing awareness about ingredient transparency, consumers actively favor excipients derived from natural sources. This has created strong momentum for manufacturers to adopt organic excipients, ensuring both safety and simplicity in their formulations.
Schedule a call with our Analysts to discuss your business needs
Dry Formulations Driving Market Momentum
The dry formulation segment is expected to grow at the highest CAGR during the forecast period. Dry excipients are in demand because they:
* Provide formulation flexibility across tablets, capsules, powders, and granules
* Enhance solubility and bioavailability of active ingredients
* Extend shelf life and stability by protecting against moisture and degradation
This versatility makes them the preferred choice across pharmaceuticals, nutraceuticals, and functional foods.
North America Holds the Largest Market Share
North America remains the largest market for nutraceutical excipients, supported by the strong presence of key global players and rising health concerns such as obesity and cardiovascular diseases. Consumers in the region are increasingly turning to nutraceuticals for preventive healthcare, directly boosting demand for excipients that make these products effective and reliable.
Key Market Players
Leading companies shaping the nutraceutical excipients market include:
* International Flavors & Fragrances Inc (US)
* Kerry Group plc (Ireland)
* Ingredion (US)
* Sensient Technologies Corporation (US)
* BASF SE (Germany)
* Roquette Frères (France)
* Cargill, Incorporated (US)
* Associated British Foods plc (UK)
* Ashland (US)
* And several others including IMCD, Hilmar Cheese Company, Azelis Group, and Biogrund GmbH
These nutraceutical excipients players are investing heavily in innovation, clean-label solutions, and advanced formulations to meet evolving consumer expectations.
News From
MarketsandMarkets™
Category: Industry Reports & Market Analysis Profile: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, w …
This email address is being protected from spambots. You need JavaScript enabled to view it.
